Search research articles
Contact Us
Filters
Showing results (61-70 of 111) with videos related to
Page
of 12
Sort By:
Internal Medicine Journal
|
February 1, 2024
Quality use of publicly subsidised tapentadol in Australia: a population-based analysis
Ximena Camacho, Andrea L Schaffer, Jonathan Brett, et al.
Pharmacoepidemiology and Drug Safety
|
December 28, 2017
Trends in opioid utilisation in Australia, 2006-2015: Insights from multiple metrics
Emily A Karanges, Nicholas A Buckley, Jonathan Brett, et al.
Therapeutic Drug Monitoring
|
November 29, 2012
Antifungal use and therapeutic monitoring of plasma concentrations of itraconazole in heart and lung transplantation patients
Jonathan Brett, OiFong Chong, Garry G Graham, et al.
British Journal of Clinical Pharmacology
|
December 4, 2025
Equity and quality use of medicines in people who present to the Psychiatric Alcohol and Non-Prescription Drug Assessment Unit
Jana Stojanova, Elysse Bo Kwan Choy, Jonathan Brett, et al.
Drug and Alcohol Review
|
October 21, 2022
Phenobarbital to manage severe gamma-hydroxybutyrate withdrawal: A case series
Georgia Freeman, Krista J Siefried, Darren M Roberts, et al.
Drug and Alcohol Review
|
May 23, 2022
Barriers to help-seeking among music festival attendees in New South Wales, Australia
Robert Page, Amy Healey, Krista J Siefried, et al.
Emergency Medicine Journal : EMJ
|
April 14, 2026
Unlocking clinical narratives: how natural language processing and artificial intelligence can address data deficits and mitigate health inequities in urgent and emergency care
Chris Humphries, Lisa Schölin, Gearóid Brennan, et al.
The Australian and New Zealand Journal of Psychiatry
|
August 24, 2022
Patterns of attention deficit hyperactivity disorder medicine use in the era of new non-stimulant medicines: A population-based study among Australian children and adults (2013-2020)
Claudia Bruno, Alys Havard, Malcolm B Gillies, et al.
British Journal of Clinical Pharmacology
|
February 21, 2024
Estimation of adherence to urate-lowering therapy in people living with gout using Australia's Pharmaceutical Benefits Scheme and patient-reported dosing
Marcel Schulz, Matthew J Coleshill, Richard O Day, et al.
BMJ Quality & Safety
|
August 8, 2018
Low-value care in Australian public hospitals: prevalence and trends over time
Tim Badgery-Parker, Sallie-Anne Pearson, Kelsey Chalmers, et al.
Page
of 12
Search research articles
Search
Showing results (61-70 of 111) with videos related to
Sort By:
Page
of 12
Internal Medicine Journal
|
February 1, 2024
Quality use of publicly subsidised tapentadol in Australia: a population-based analysis
Ximena Camacho, Andrea L Schaffer, Jonathan Brett, et al.
Pharmacoepidemiology and Drug Safety
|
December 28, 2017
Trends in opioid utilisation in Australia, 2006-2015: Insights from multiple metrics
Emily A Karanges, Nicholas A Buckley, Jonathan Brett, et al.
Therapeutic Drug Monitoring
|
November 29, 2012
Antifungal use and therapeutic monitoring of plasma concentrations of itraconazole in heart and lung transplantation patients
Jonathan Brett, OiFong Chong, Garry G Graham, et al.
British Journal of Clinical Pharmacology
|
December 4, 2025
Equity and quality use of medicines in people who present to the Psychiatric Alcohol and Non-Prescription Drug Assessment Unit
Jana Stojanova, Elysse Bo Kwan Choy, Jonathan Brett, et al.
Drug and Alcohol Review
|
October 21, 2022
Phenobarbital to manage severe gamma-hydroxybutyrate withdrawal: A case series
Georgia Freeman, Krista J Siefried, Darren M Roberts, et al.
Drug and Alcohol Review
|
May 23, 2022
Barriers to help-seeking among music festival attendees in New South Wales, Australia
Robert Page, Amy Healey, Krista J Siefried, et al.
Emergency Medicine Journal : EMJ
|
April 14, 2026
Unlocking clinical narratives: how natural language processing and artificial intelligence can address data deficits and mitigate health inequities in urgent and emergency care
Chris Humphries, Lisa Schölin, Gearóid Brennan, et al.
The Australian and New Zealand Journal of Psychiatry
|
August 24, 2022
Patterns of attention deficit hyperactivity disorder medicine use in the era of new non-stimulant medicines: A population-based study among Australian children and adults (2013-2020)
Claudia Bruno, Alys Havard, Malcolm B Gillies, et al.
British Journal of Clinical Pharmacology
|
February 21, 2024
Estimation of adherence to urate-lowering therapy in people living with gout using Australia's Pharmaceutical Benefits Scheme and patient-reported dosing
Marcel Schulz, Matthew J Coleshill, Richard O Day, et al.
BMJ Quality & Safety
|
August 8, 2018
Low-value care in Australian public hospitals: prevalence and trends over time
Tim Badgery-Parker, Sallie-Anne Pearson, Kelsey Chalmers, et al.
Page
of 12